Intuitive Surgical Exec Says Planned 2027 Extended-Use Instrument Program Could Provide Tailwind To Procedure Growth As Investors Weigh Slowing U.S. Growth; Bariatrics Is Just Over 2% Of Global da Vinci Procedures, With Its Incremental Impact Moderating Over Time